A Phase I, Single Centre, Open-Label Study to Assess the Pharmacokinetics of Both AZD5672 (Steady-State) and Atorvastatin (Single Dose) When Co Administered in Healthy Volunteers.

Trial Profile

A Phase I, Single Centre, Open-Label Study to Assess the Pharmacokinetics of Both AZD5672 (Steady-State) and Atorvastatin (Single Dose) When Co Administered in Healthy Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 30 Nov 2010

At a glance

  • Drugs Atorvastatin; AZD 5672
  • Indications Hypercholesterolaemia; Hypertriglyceridaemia; Low HDL cholesterol; Rheumatoid arthritis
  • Focus Pharmacokinetics
  • Sponsors AstraZeneca
  • Most Recent Events

    • 30 Nov 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 30 Nov 2010 Actual end date (Aug 2008) added as reported by ClinicalTrials.gov.
    • 28 Sep 2008 Planned end date changed from 1 Oct 2008 to 1 Aug 2008 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top